| Literature DB >> 30862029 |
Seok Hee Seo1, Sang-Mi Jo2, Jiyoung Kim3, Myoungsook Lee4, Yunkyoung Lee5, Inhae Kang6.
Abstract
Peanut sprouts (Entities:
Keywords: adipogenesis; fatty acid oxidation; mitochondrial respiration; peanut sprouts; resveratrol
Mesh:
Substances:
Year: 2019 PMID: 30862029 PMCID: PMC6429123 DOI: 10.3390/ijms20051216
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Total polyphenol, flavonoid, and resveratrol contents of peanut sprout extract.
| Total polyphenols, Flavonoids, and Resveratrol Contents | Peanut Sprout Extract |
|---|---|
| Total polyphenols (mg Gallic acid/extract g) | 10.87 ± 0.11 |
| Total flavonoids (mg Catechin/extract g) | 3.79 ± 0.14 1 |
| Resveratrol (μg/g) | 18 |
1 Values are presented as the mean ± SEM of three independent experiments.
Figure 1Effects of PSE on cell viability in 3T3-L1 and C3H10T1/2 pre-adipocytes. The culture of 3T3-L1 (A) and C3H1051/2 cells (B) were treated with 10‒100 μg/mL of PSE for 24 h. XTT reagent was added 3 h before measurement of OD 450 nm. Data are expressed as a percentage of the vehicle control (dimethyl sulfoxide (DMSO)). n.s. represents no significance. Data are represented as the mean ± SEM of three independent experiments. Values that do not share the same superscript are significantly different, as determined by one-way ANOVA (p < 0.05).
Figure 2PSE inhibits adipogenesis in 3T3-L1 adipocytes. 3T3-L1 cells were seeded and induced to differentiation in the presence of DMSO (vehicle control), resveratrol (20–40 μM) or PSE (50–200 μg/mL) for 10 days: (A) TG accumulation in 96-well culture plates was visualized by ORO staining; (B) extracted ORO staining was quantified (OD 500 nm); (C) representative images from three separate experiments (magnified 4×); (D) adipogenic gene expression of PPARγ, aP2, C/EBP α, and Fas by qPCR; (E) adipogenic protein expressions of PPARγ, aP2, phosphor-specific, or total antibodies targeting AMPK and β-actin by Western blot analysis. All values are presented as the mean ±S.E.M. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 compared with the vehicle control (DMSO treated cells) by one-way ANOVA with Bonferroni’s comparison test. +; treatment, -; non-treatment.
Figure 3PSE inhibits adipogenesis in C3H10T1/2 mouse embryonic fibroblasts, adipocytes, and EMSCs. C3H10T1/2 cells were seeded and induced to differentiation in the presence of either DMSO (vehicle control) and PSE (5–100 μg/mL) for four days: (A) Triglyceride accumulation was visualized by Oil red-O staining and representative images from three separate experiments are shown in (left) (magnified 4×); extracted ORO staining was quantified (OD 500 nm) (right). Primary adipocytes were prepared from EMSC of Balb/c mice: (B) Phase contrast images of primary adipocytes were differentiated with or without PSE (25 μg/mL) for seven days (magnified 4×, scale bar = 400 μm); (C) adipogenic gene expression of PPARγ and aP2 by qPCR. * p < 0.05; ** p < 0.01; **** p < 0.0001 compared with the vehicle control (DMSO treated cells) by one-way ANOVA with Bonferroni’s comparison test or Student’s t-test. +; treatment, -; non-treatment.
Figure 4PSE attenuates lipid accumulation in cultures of adipocytes by upregulating fatty acid oxidation and mitochondrial oxygen consumption. (A) Experimental scheme. 3T3-L1 were seeded on the second day before differentiation (d-2) and induced to differentiation (d0, MDI: methyl isobutyl- xanthine, dexamethasone, and insulin). Keep 3T3-L1 cells differentiated into fully differentiated adipocytes until d7. Fully differentiated adipocytes (d7) were incubated with PSE (25 μg/mL) for three days. (B) Lipogenic and fatty acid oxidation-related gene expression of PPARγ, aP2, PGC1α, CPT1, and PPARα as determined by qPCR. (C) Conversion of [3H]-OA into [3H]-H2O. (D–F) Oxygen consumption rate (OCR) in 3T3-L1 adipocytes treated with Veh (blue) and PSE (red) as determined by Seahorse extracellular analyzer. 3T3-L1 cells differentiated into fully differentiated adipocytes. Fully differentiated adipocytes (d7) were incubated with PSE (25 μg/mL) for one day. Arrow indicates the addition of respiratory inhibitors of oligomycin (Oligo), carbonyl cyanide 4-trifluoromethoxy phenylhydrazone (FCCP) and a combination of antimycin A and rotenone (Rot/AA). (G–H) OCR in HepG2 cells treated with BSA (black), PA (blue), and PA + PSE (red) as determined by Seahorse extracellular analyzer. HepG2 cells were pre-incubated with PSE (50 μg/mL)for 48 h. BSA or 0.8 mM BSA-PA complex was loaded for 3 h. (I) Relative expressions of UCP1 and PGC1α by qPCR. Pre-treatment of the 3T3-L1 cell with PSE for 7 d during adipogenesis, followed by Bt2-cAMP stimulation for 6 h. All values are presented as the mean ±SEM. n.s. represents no significance. * p < 0.05; ** p < 0.01; *** p < 0.001 compared with the vehicle control (DMSO-treated cells) by Student’s t-test or one-way ANOVA with Bonferroni’s comparison test. Means that do not share a common superscript are significantly different as determined by one-way ANOVA with Bonferroni’s comparison test. ++ p < 0.01; +++ p < 0.001 compared with the vehicle control (DMSO treated cells) # p < 0.05; ## p < 0.01; ### p < 0.001 compared with PA-treated HepG2 cells by two-way ANOVA with Bonferroni’s comparison test. +; treatment, -; non-treatment.